Scientific Sessions 2025  /  TCT at AHA: Hot Topics in Pulmonary Embolism  /  What Next After Establishing the Diagnosis: Risk Stratification for Acute PE
Logo

American Heart Association

  91
  0

Final ID:

What Next After Establishing the Diagnosis: Risk Stratification for Acute PE

  • Piazza, Gregory  ( BWH , Boston , Massachusetts , United States )
  • Secemsky, Eric  ( Beth Israel Deaconess Medical Cente , Boston , Massachusetts , United States )
    • Author Disclosures:
    Gregory Piazza: DO have relevant financial relationships ; Researcher:BMS/Pfizer, Janssen, Alexion, Bayer, Amgen, BSC, Regeneron, NIH 1R01HL164717-01:Active (exists now) ; Advisor:BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen:Active (exists now) | Eric Secemsky: DO have relevant financial relationships ; Consultant:Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx , Medtronic, Philips, RapidAI, Rampart, R3, Shockwave , Siemens, Son i Vie, Teleflex, Terumo, Thrombolex, VentureMed , Zoll:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Hot Topics in Pulmonary Embolism

Sunday, 11/09/2025 , 03:30PM - 04:30PM

Cardiovascular Seminar

More abstracts on this topic:
What is in the Toolbox for Chronic PE à The CTEPH Patient?

Aggarwal Vikas, Rosenfield Kenneth

Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches

Wiss Aaron, Rosenfield Kenneth, Lookstein Robert, Secemsky Eric, Giri Jay

More abstracts from these authors:
Identifying Predictors of Durable Treatment Response among Patients with Claudication; A Secondary Analysis of the CLEVER Trial

Hentati Firas, Secemsky Eric

The Good, the Bad, and the Rare: vascular jeopardy of uncommon vascular disease

Henkin Stanislav, Ratchford Elizabeth, Piazza Gregory

You have to be authorized to contact abstract author. Please, Login
Not Available